Utah Medical Products
UTMD
98 hedge funds and large institutions have $266M invested in Utah Medical Products in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 6 closing their positions.
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
44% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 27
10% more capital invested
Capital invested by funds: $241M → $266M (+$25.2M)
7% more funds holding
Funds holding: 92 → 98 (+6)
1.32% more ownership
Funds ownership: 72.99% → 74.31% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$3.56M |
| 2 |
BlackRock
New York
|
+$3.16M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$2.78M |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$2.38M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
-$13.7M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.07M |
| 3 |
Man Group
London,
United Kingdom
|
-$343K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$332K |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$289K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Millennium Management
New York
| – | -$202K | -2,289 | Closed |
|
102
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
| – | -$18K | -200 | Closed |
|
|
TRCT
103
Tower Research Capital (TRC)
New York
| – | -$2K | -22 | Closed |
|
|
RTC
104
Riverview Trust Company
Vancouver,
Washington
| – | -$1K | -15 | Closed |
|
UTMD Hedge Fund Activity: Q2 2019 in Review
98 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2019, worth a combined $266M — up 10% from $241M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new UTMD positions and 6 closed out — a net gain of 8 holders — while 39 added to existing stakes and 27 trimmed.
The largest buyer was Russell Investments Group, adding an estimated $3.56M. The largest seller was Lazard Asset Management, exiting entirely with an estimated $13.7M sold.
- 98 institutional investors held Utah Medical Products (UTMD) as of Q2 2019, up from 92 in Q1 2019.
- Funds reported $266M of Utah Medical Products stock for Q2 2019, up 10% quarter-over-quarter.
- 14 funds opened new Utah Medical Products positions in Q2 2019 and 6 closed out, a net change of +8 holders.
- The largest Utah Medical Products buyer in Q2 2019 was Russell Investments Group, an estimated $3.56M added.
- The largest Utah Medical Products seller in Q2 2019 was Lazard Asset Management, an estimated $13.7M sold.
Based on aggregated 13F filings for Q2 2019.